Our in vivo experimental data presents compelling evidence supporting the inhibitory effects of NRF2 or GPX4 inhibition on the growth and dissemination of ovarian cancer within the peritoneal cavity of mice. This evidence concerns the gene GPX4 and ovarian cancer.